Medical research

Institute working to accelerate COVID-19 drug development

As part of ongoing efforts to make a live attenuated vaccine for COVID-19, Texas Biomedical Research Institute Professor Luis Martinez-Sobrido and his team developed a weakened, or attenuated, version of SARS-CoV-2 that does ...

Diseases, Conditions, Syndromes

Examining COVID-19 and its many sublineages

As new omicron subvariants of COVID-19 continue to sweep across the United States, researchers at the University of Missouri have identified specific mutations within the virus' spike protein that help omicron subvariants ...

page 11 from 40